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Abstract The time is near where ‘therapeutic’ bodily
assistive devices, developed to mimic species-typical
body structures in order to enable normative body
functioning, will allow the wearer to outperform the
species-typical body in various functions. Although
such devices are developed for people that are seen to
exhibit sub species-typical abilities, many ‘therapeutic
enhancements’ might also be desired and used by
people that exhibit species-typical body abilities. This
paper presents the views of members of the World
Federation of the Deaf on potential beyond species-
typical abilities enabling therapeutic assistive devices
(i.e. related to hearing). Survey respondents showed
support for the development and uptake of beyond
normal hearing enabling devices. The views of survey
respondents as clients affect hearing-enabling profes-
sions (such as audiologist and speech pathologists).
The paper analyzes what guidance code of ethics of
hearing enabling professions give in regards to
beyond normal hearing enabling devices. This paper
suggests that people labeled impaired and the pro-
fessions that serve them should more involved in the
enhancement discourse.
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Introduction
Science and technology usage, research, and devel-
opment are often articulated in terms of better and/
or more sustainable health and rehabilitation care,
better health, more efficient health systems, and
health and rehabilitation care delivery [1]. This
affects all facets of health and rehabilitation, includ-
ing understanding and scope of health and rehabil-
itation and expectations of health and rehabilitation
clients and professionals. The discourse around
health and rehabilitation traditionally is based on
species-typical normative body functioning as its
framework of reference [2–7]. This frame of refer-
ence is slowly changing. ‘Therapeutic’ bodily devi-
ces, developed to mimic species-typical body
structures and expected body functioning and used
by people who are labeled impaired, increasingly
allow this wearer to outperform the species-typical
body in various functions. The cheetah artificial legs
of Paralympic athletes such as Oscar Pistorius [8–
12], Aimee Mullins [13, 14] or Sarah Reinertsen [15]
are just several examples of such enhancement-
enabling ‘therapeutic’ devices and are a harbinger
of change to come. Other devices include brain–
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prostheses; wheelchair control; bionic legs and arm;
bionic knee; neural prostheses; speech; artificial
joints, artificial muscles, bioartificial kidney, artifi-
cial liver, artificial cartilage artificial lungs, artificial
discs, artificial pancreas bionic dental pulp and other
areas all advancing [1, 16, 17].
Various ‘therapeutic assistive devices’ are linked to
restoring hearing, speaking and communication. One
example of new abilities related to speech not existing
in humans would be the sub-vocal speech device from
Ambient Incorporate [18]. This device is capable of
processing neurological information from the brain
into synthesized speech allowing, among other func-
tions, for the thought-controlled movement of a
wheelchair [18]. Hearing aids and cochlear implants
might outperform the normal hearing in the future
[19, 20]. Additionally, there are brain machine
interfaces [16, 21–23] that may potentially change
the nature of communication (e.g. communicating
through computers, aka techlepathy).
A lively discourse exists around the advisability
and impact of the development of artificial ears,
cochlear implants and external hearing devices.
This involves deaf people who want to obtain the
hearing ability of the species-typical human and
deaf people who feel that hearing is not an essential
ability (often this population aligns with a belief in
deaf culture). It includes parents (deaf and not deaf)
of deaf children; hard of hearing people that want
to regain their species-typical hearing; hard of
hearing people who do not; professionals that are
involved in informing the ‘impaired’ client of the
devices; professionals who perform the interven-
tions and training if needed and the ones producing
the devices [24–30].
This discourse to date centers around the end goal
of enabling species-typical hearing abilities—with
some defending the efforts to generate species-
typical hearing abilities, and with others questioning
the label of ‘impairment’ for the decrease in as
species-typical’ perceived hearing ability. The latter
perceive a decrease in hearing abilities as a variation
in human abilities and do not see the need to obtain
species-typical hearing.
However, increasingly a narrative of body ability
perception and intervention is emerging that enter-
tains the vision of moving beyond the species-
typical. This is facilitated by availability of ‘en-
hancement drugs’ that lead to transient abilities
beyond the normal (not the focus of this paper) and
the increasing availability of therapeutic assistive
devices that allow body abilities to move perma-
nently beyond the species-typical. In the case of
neuro-devices brain machine interfaces, sub-vocal
speech, artificial hippocampus and cochlear
implants/hearing aids might allow wearers to move
beyond the species-typical in speech, hearing and
communication abilities. The paper focuses on the
possibility of deaf and hard of hearing people as
potential consumers of hearing devices which
enable beyond species-typical hearing abilities.
These consumers might perceive beyond the
species-typical hearing to be a valuable avenue to
gain respect and quality of life.
Despite the changing narrative, these populations
(deaf, hard of hearing people, the hearing profession,
and parents of deaf and hard of hearing children) are
not visible in the enhancement discourse. Indeed no
real discourse exists that addresses the future possi-
bility of beyond species-typical hearing enabled by
such devices.
This paper analysis the views of members of the
World Federation of the Deaf on the topic of beyond
‘normal’ hearing enabled by assistive devices and the
use of other beyond species-typical ability enabling
devices (brain machine interfaces, artificial hippo-
campus, artificial organs and artificial eyes, noses,
arms, legs, skins, retinas and sub-vocal speech
devices). Results are obtained through an exploratory,
non-probability survey.
Many ‘therapeutic’ enhancements could also be
applied to and desired by species-typical people.
Neuroenhancement of the ‘healthy by using medica-
tion developed for ‘neuro diseases’ is a reality and a
recognized issue [31–40]. A recent survey of 1,427
readers of the journal Nature revealed that 79% felt
that healthy people should be allowed to take
cognitive enhancers [41]. One-third of respondents
said they would feel pressure to give cognition-
enhancing drugs to their children if other children at
school were taking them [41]. Outram and Racine
(2011) describe a emerging public health framework
around cognitive enhancements [42].
This paper highlights the sentiments of members of
the World Federation of the Deaf as to the ‘non-
impaired’ having access to devices that increase
hearing beyond the species-typical and other beyond
the species-typical enabling devices.
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Therapeutic enhancement in general and in partic-
ular the aspect that they can be used for other
purposes impact many professions. A study by Banjo
reports that physicians prefer to give neuroenhance-
ments to older over younger people as the enhance-
ment treatment of the elder is seen more as a
restoration of a cognitive ability which has declined
with age [43] According to Geppert (2011) enhance-
ments are rarely discussed among psychiatrists [39].
The Ethics, Law and Humanities Committee Ameri-
can Academy of Neurology generated a report in
2009 with the aim,
“to provide neurologists with an overview of the
ethical, legal, and social issues surrounding the
use of pharmaceuticals prescribed to enhance or
augment normal cognitive or affective function-
ing, as well as practical guidance for responding to
an adult patient’s request for neuroenhancement”
[31].
Audiologists, logopedists, and speech patholo-
gists are some professions that are involved with
deaf and hard of hearing people that want to obtain
hearing enabling devices. This paper explores
possible avenues for action for hearing professions,
given their codes of ethics, in regards to devices
which enable beyond the species-typical hearing
ability.
Method
An online delivered exploratory non-probability sur-
vey (using a combination of 23 simple yes or no,
Likert scale, as well as opinion rating scale questions)
was developed. Seven questions covered various
demographic angles. Two questions asked whether
the respondent opposed cochlear implants or hearing
aids. Two questions covered the topic of sign
language (not covered in this paper). Six questions
covered the area of future abilities of cochlear
implants and hearing aids to outperform the ‘spe-
cies-typical’ hearing. Five questions covered non
hearing related therapeutic enhancement enabling
interventions. The survey received ethics approval
by University of Calgary Health Research Ethics
board and gained approval by members of the World
Federation of the Deaf responsible for such decision.
The author received the notice of approval from the
executive of the World Federation of the Deaf by
email. After approval was obtained the link to the
survey was given to the executive director of the
World Federation of the Deaf who sent the link to
those holding memberships. The response rate of 71
people with a 60.6% completion rate was very low
assuming that the World Federation can reach many
thousand people. As a result, the survey results cannot
be generalized. This was expected by staff of the
World Federation of the Deaf, as the survey was in
English and not in sign language. However, the
potential for the survey to generate preliminary data
that would provide the foundation for another more
accessible survey was recognized. Data of this
preliminary survey were seen to provide an avenue
whereby members of local deaf and hard of hearing
groups, and rehabilitation professionals linked to
them, could participate in focus groups and interviews
(adding qualitative data to the mostly quantitative data
presented here). A database was automatically gener-
ated by Survey Monkey. Data was exported as pdf
files for subsequent analysis. Frequency distribution
analysis of answers were performed as well as cross
tabulation analysis of the results related to the
following demographics: Self perception: ‘Normal’;
Perception by others as and Self perception: impaired;
Perception by others as impaired; I am hard of hearing
and perceive it as something to be fixed; I am hard of
hearing and do NOT perceive it as something to be
fixed; I am deaf from birth and perceive deafness as
something to be fixed; I am deaf from birth and
perceives deafness within a Deaf Culture Framework
(all of these perceptions were options the respondent
could choose from, they could also comment on these
options and give new options by adding comments
but no comments were gives).
Results
Demographics
Forty-one respondents or 77.4% were from Aus-
tralia; three from Canada, four from Finland, one
from Ireland, Sweden, Norway, Slovenia, United
States. 88.9% (n=48) were between the ages of 30
and 65. 21.8% (n=8) stated that they are hard of
hearing and perceive it as something to be fixed and
18.9% (n=7) stated that they are hard of hearing and
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do NOT perceive it as something to be fixed. As for
people who self identified as deaf, 18.9% (n=7)
believed they should be fixed and 32.2% (n=12)
believed in deaf culture. 8.1% (n=3) stated that they
are a parent of a deaf child and believe in Deaf
culture. 5.4% (n=2) stated they are a parent of a deaf
child and feel their child should hear. 10.8% (n=4)
stated they are a parent of a hard of hearing child and
believe in Deaf culture. 5.4% (n=2) stated that they
are a parent of a hard of hearing child and feel s/he
should hear better.
Sentiment Towards Hearing Devices
N=73 do not oppose cochlear implants for themselves
or others whereas n=18 oppose cochlear implants for
themselves or others (multiple answers possible).
N=45 do not oppose hearing aids for themselves or
others whereas n=2 oppose hearing aids.
Sentiment Towards Different Intervention Options
The respondents were given these three intervention
options
1) Direct changes to the hearing ability of the person
through today’s existing internal hearing aids
such as cochlear implant
2) Direct changes to the hearing ability of the person
through today’s existing external non-implantable
hearing aids
3) Modification of the environment to allow people
to function satisfactory independent of their level
of hearing
The weighted mean for option 1 was 3.51 out of 5;
for option 2 was 4.22 out of 5 and for option 3 was
4.1 out of 5. However, comments given by the
respondents in the comment box indicates that many
felt all three as equally important or that the option to
choose depends on the circumstances, for example
access to option 1 or 2.
Hearing Beyond the Normal
If asked whether we should develop internal or
external hearing aids that generate hearing abilities
that go beyond the species-typical hearing abilities of
humans 53.5% (n=23) answered with yes; 32.6% (n=
14) answered with No and 14.0% (n=6) answered
with Don’t Know.
To give for one question the answers cross-
tabulated for respondents that oppose and do not
oppose wearing hearing aids the results are:
& Of respondents who did not oppose wearing
external hearing aids 51.4% (n=19) answered
with Yes 35.1% (n=13) answered with No and
13.5% (n=5) answered with do not know.
& Of respondents who did not oppose wearing
internal hearing aids 51.4% (n=18) answered with
Yes 34.3% (n=12) answered with No and 14.3%
(n=5) answered with do not know.
& Of respondents who oppose wearing external
hearing aids (n=2) 100% answered with Yes.
& Of respondents who oppose wearing internal
hearing aids 57.1% (n=4) answered with Yes
42.9% (n=3) answered with No.
To give for one question the answers cross
tabulated related to how one perceives oneself and
how one is perceives by others one obtains the
following numbers (Table 1).
Comment given in the comment box to this
question indicate that many of the respondents are
skeptical whether such devices will ever appear as
they feel that the devices have not even reached
normal hearing quality yet. Others came up with
concrete examples of what could be added to hearing
devices such as greater range of frequencies, greater
Table 1 Question 13. Should we develop internal or external hearing aids that generate hearing abilities that go beyond the hearing
abilities exhibited by ‘normal’ hearing
Yes No Don’t know
Self perception: ‘Normal’; Perception by others as ‘Normal’ 46.7% (n=7) 46.7% (n=7) 6.7% (n=1)
Self perception: ‘Normal’; Perception by others as impaired 30.0 (n=3) 40.0 (n=4) 30.0 (n=3)
Self perception: Impaired; Perception by others as ‘Normal’ 66.7 (n=4) 0 33.3 (n=2)
Self perception: impaired; Perception by others as impaired 90.0% n=(9) No 10.0% (n=1) 0
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distance, heightened musical appreciation and sounds
that humans cannot hear. Many also felt that if such
abilities would be added to hearing aids that these
devices would first be available to the hearing people.
Impact
Question 17 asks about the impact of beyond the
normal hearing enabling devices on (People who
belief in Deaf culture; People who perceive them-
selves as hearing impaired; Other disabled people of
‘normal’ hearing; Rehabilitation Professionals;
Speech Pathology professionals; Occupational Thera-
py Professionals; Physical Therapy Professionals;
Audiologists; Community Rehabilitation). The only
group who is seen as being impacted mostly
negatively (50% n=21) is the group of people who
belief in Deaf culture. For all the others a solely
negative effect was below 4%. For all groups 14–24%
of respondents saw a positive and negative effect.
Other disabled people of ‘normal’ hearing 26.8% (n=
11) and Physical Therapy Professionals 31.7% (n=13)
are the two groups seen as the most non-impacted.
For the other groups the non-impacted answer was
below 10%. As to a solely positive impact, the
numbers were between 48% and 65% for: People
who perceive themselves as hearing impaired; Reha-
bilitation Professionals; Speech Pathology professio-
nals; Occupational Therapy Professionals;
Audiologists; Community Rehabilitation. The lowest
number 14.3% (n=6) existed for People who belief in
Deaf culture with second lowest 24.4% (n=10) for
other disabled people of ‘normal’ hearing.
As to the impact, covered in question 17 question
18 allowed respondents to offer their thoughts. In
regards to impact on people that believe in deaf
culture, 11 respondents felt that enhancement would
be a threat to the continued existence of Deaf culture
and people believing in Deaf culture might feel
threatened. One respondent felt that the discourse
would move from Deaf culture towards cyborg
culture. As to people who perceive themselves as
hearing impaired, the qualitative answers did mention
increase of positive feelings such as self esteem n=3
but the comments were mostly N/A and ‘it’s just a
nice bonus’. Two comments highlighted that the use
of beyond normal enabling hearing devices might
lead to a conflict with the normative hearing people.
As to impact on professionals comments beside N/A
centered around increased opportunity for professio-
nals to help.
Non-hearing Related Therapeutic Devices that Enable
Beyond Species-Typical Abilities
As to question 19 which asks whether therapeutic
enhancement products (Brain Machine Interfaces;
Artificial Hippocampus; Subvocal Speech device;
Artificial Organs; Artificial Nose; Artificial Legs;
Artificial Arms; Artificial Eyes; Artificial Retina;
Artificial Skin) should be developed and made
accessible to disabled people the Yes response rate
was between 75% and 100% for all devices.
Access for Non-disabled People
As to the question whether ‘non-disabled’ should have
access to these enhancement exhibiting therapeutic
products (question 21) 24.4% (n=10) said Yes; 53.7%
(n=22) said No and 22% (n=9) said Don’t know.
Use by Non-disabled People
As to the question whether it can be prevented that
non disabled people will use enhancement exhibiting
therapeutic products (question 22) the majority 57.5%
(n=23) felt that it could not be prevented with 25.0%
(n=10) felt they don’t know and only 17.5% (n=7)
felt it could be prevented. Furthermore 42.5% (n=17)
felt that non-disabled people will try to obtain the
devices with 35.0% (n=14) felt they don’t know and
only 22.5% (n=9) felt they won’t.
Discussion
To data, disabled people (including deaf and hard of
hearing people) and rehabilitation professionals are
mostly absent from the human enhancement beyond
the normal discourse. This paper presents the views of
members of the World Federation of the Deaf.
Although one cannot generalize the results, the views
obtained give some insight as to sentiments of
members of the World Federation of the Deaf. These
findings might be used by the World Federation of the
Deaf and other researchers to generate a survey in a
form that allows for a higher response rate (e.g.
through sign language), as well to engage other
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research subjects locally (e.g. through a survey, focus
groups, or face to face interviews).
The key findings are that the majority believes:
a) that we should develop internal and external
hearing aids that generate hearing abilities that
go beyond the hearing abilities exhibited by
‘normal’ hearing;
b) that we should also develop other therapeutic
products that enable enhancements such as brain
machine interfaces; artificial hippocampus; sub-
vocal speech device; artificial organs; artificial
noses, legs arms, eyes, retina and skin;
c) that non-disabled people should not have access
to enhancement exhibiting therapeutic products;
d) that one cannot prevent non-disabled people
from using enhancement exhibiting therapeutic
products;
e) that so called non-disabled people will try to
obtain these enhancements;
f) that there will be a mostly negative impact on
people who belief in Deaf culture;
g) there will be mostly positive or no impacts on
people who perceive themselves as hearing
impaired; other disabled people of ‘normal’
hearing; rehabilitation professionals; speech pa-
thology professionals; occupational therapy pro-
fessionals; physical therapy professionals;
audiologists and community rehabilitation.
These results, though from a small sample, seem to
support the prediction [44] that people with disabil-
ities will move towards enhancements if available and
might even push actively for such developments. It
also seems to support James Hughes, the former
executive director of the World Transhumanist Asso-
ciation, a group that promotes beyond-the-‘normal’
enhancements when he wrote, “Although few dis-
abled people and transhumanists realize it yet, we are
allies in fighting for technological empowerment
[45].” This data strengthens the idea that as sub
species-typical labelled people and people linked to
them might indeed be a trailblazer for enhancements.
One highly debated topic in the enhancement
discourse is whether therapeutic interventions should
be accessible to so called non-disabled, healthy
people [1, 31, 39, 43]. Some accept therapeutic
enhancement and reject non-therapeutic enhance-
ments. Although the survey respondents felt that
‘species-typical’ people should not have access to
these enhancements, they also felt it unpreventable
that ‘species-typical’ people would use enhancement
exhibiting therapeutic products. They anticipate that
the species-typical, the non-impaired labeled people
will succeed in obtaining enhancements. The desire
for enhancements might be greater the less invasive
they are and the more they are reversible and easily
upgradable [46]. Some might want enhancements to
stay competitive in the workplace or sport or
education [9, 47]; some might perceive themselves
as impaired (or in a state of ill health) if they stay
species-typical. They might link being healthy to
having obtained all kind of enhancements [1, 48].
Given the results of the survey, what role should
and can hearing related health care and rehabilitation
professionals play and what actions should they take
in regards to hearing beyond the normal enabling
devices? Codes of ethics exist for members of many
professional organizations to provide guidance as to
how to act. What guidance can they give in regards to
hearing beyond the normal enabling devices? The
author analyzed the American Academy of Audiology
[49], Academy of Doctors of Audiology® [50],
Audiological Society of Australia [51], College Of
Audiologists and Speech Language Pathologists [52],
Canadian Association of Speech-Language Patholo-
gists and Audiologists (CASLPA) [53] and the
Standing Liaison Committee of E.U. Speech and
Language Therapists and Logopedists [54] code of
ethics. The codes of ethics states among others:
To keep in mind the dignity, worth, and rights of
those served [49]; to protect the welfare of
persons served professionally [50]; to carefully
assess and document the patient’s physical,
social, emotional and occupational needs [50];
to inform “patients of the recommended services
or products and any reasonable alternatives in a
manner which allows the patient to become
involved in, and make informed, treatment
decisions.” [50]; “The welfare of the client,
students, research subjects and the public must
take precedence over a member’s self interest,
or the interest of employers or colleagues [51];
“to choose the right, fair, good and just action”
[52]; “apprise patients/clients of programs and
services from which they may benefit”; [52]
“The primary ethical obligation of audiologists
and speech-language pathologists is to practice
their skills for the benefit of their patients/
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clients” [52]; “The welfare and dignity of those
served professionally is paramount” [53]; to
“contribute to the wellbeing of all individuals
who access these services, in accordance with
the European Convention of Human Rights”
[54]; “to have respect for the autonomy and
dignity of individuals” [54]; “to act in such a
way as to bring benefits to individuals and to
improve their quality of life” [54].
The guidance ‘best interest for the person’ is used
by three of the five codes of ethics investigated [49,
50, 54]. It could be interpreted to obligate profes-
sionals guided by these three code of ethics to offer
enhancement products to their deaf and hard of
hearing clients. This is especially true if it appears
that beyond species-typical hearing leads to a better
quality of life for the person, or more opportunities
(another guidance parameter mentioned in the code of
ethics) [54]. However, quality of life has many
different facets. Many different quality of life indica-
tors exist [55–72], so which one is one to follow? The
situation is further complicated by the fact that the
quality of life of disabled people and the life of people
linked to them is constantly underestimated (many
references in [1]). Furthermore, how does the reha-
bilitation professional know whether the enhancement
is the best way to increase the quality of life or
whether some social changes might be more useful?
Some caution about the constant move beyond is
mentioned in Downie and Koester (2008) [73].
Linked to the theme of ‘best interest of the person’
is the theme of ‘preventing injury and harm to the
person’ [49–51, 54]. These two themes together ask
for a risk benefit analysis. Could the access to
enhancements do more harm than good? Especially
with non reversible invasive interventions could the
person feel obsolete given that there might be another
‘better’ version coming out eventually? [46] Some of
the comments of the respondents in the survey
highlight that some respondents are concerned that
an enhancement might change the relationship of the
receiving person with others. They do not stand alone
with this concern. Wolbring (2010) [46] provides the
example of the World Professional Association for
Transgender Health (WPATH). They have strict
eligibility criteria for hormone therapy and/or
genital-reconstructive surgery because of its more or
less irreversibility. “The criteria include participation
in psychotherapy, the requirement to live at least
1 year full-time in the preferred gender role to
develop resilience in coping with the inevitable
psychosocial challenges [74].” [46] The “tasks of the
mental-health professional include assessment of
gender identity and the impact of stigma on psycho-
logical adjustment; treatment of coexisting mental-
health concerns; confronting internalized transphobia
and grieving for the left behind gender identity [74]”
[46]. The case of the WPATH raises the question
whether rehabilitation professions with deaf and hard
of hearing clients should be required to develop
guidelines in regards to enhancements to prevent
emotional harm for their clients? The enhanced deaf
and hard of hearing persons might lose their bond
with the non-enhanced they related to so far. The
enhancement might trigger envy and they might
become isolated; they might become stigmatized.
They might have sensory inputs they regret later.
The Nature survey [41] mentioned in the introduction
highlights the danger of peer pressure. Peer pressure
susceptibility is known to have an impact on the
ability to refuse (see for example [75]). The above
leads to the question of whether rehabilitation
professionals have to start generating risk benefit
analysis data around enhancement, which will be a
complicated endeavor which takes some time. It
might be good to start the process before the products
are actually available as risk benefit calculations are
not simple “putative benefits are difficult to quantify”
as the report of the ethics committee of the American
Academy of Neurology acknowledges [31].
Then there is the economic factor. Almost inevitably,
not everyone will be able to afford the enhancements.
As the report from the ethics committee of the American
Academy of Neurology states: “Neuroenhancement
therapies are likely to be seen as “lifestyle” drugs and
therefore are unlikely to be covered by third-party
payers. Whether such an inequality of distribution will
provide a sufficient basis to prohibit the use of neuro-
enhancement at all is an issue that will have to be
addressed by the medical profession and society” [31].
Indeed various codes of ethics talk about the non
discrimination against their clients based on general
health [49] handicapping condition [50] the nature of
their illness [51] and disability [52] (whereby 53 uses
disability with the meaning of impairment, defect, sub
species-typical). One could interpret the wording of the
code of ethics to indicate that the profession has to ensure
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access to such emerging devices for their ‘impaired’, sub
species-typical clients as a way to minimize negative
consequences (assuming that a benefit risk analysis
performed concludes that the benefits are higher). For the
clients that cannot obtain enhancement products, they
might have to find ways to minimize the detrimental
effects linked to not being enhanced.
The prohibition of discrimination of services based
on general health opens the door for the profession
having to serve also the so-called species-typical
hearing people with enhancement devices if they
wish so. If devices which enhance hearing used by
deaf and hard of hearing people lead to some
advantages, a so-called normal hearing person could
claim that their general health is affected due to
decrease in opportunity i.e. employment due to a lack
of competitiveness. As such, the person could seek
the devices to ‘level the playing field.’
Conclusion
Given that (a) increasing ability, access to, demand
for, and acceptance of changing, improving, modify-
ing and enhancing the human body in terms of its
structure, function or capabilities beyond its Homo
sapiens-typical boundaries leads to a changed under-
standing of oneself, one’s body, and one’s relationship
with others of the species, other species and the
environment [1, 16, 41, 48, 76–79], (b) the answers
by the survey respondents and (c) the themes of
responsibility evident in the codes of ethics, it might
be pertinent that the enhancement discourse is
discussed more broadly by more stakeholders. It
additionally might be prudent to develop guidelines
on the enhancement topic such, as was developed by
the American Academy of Neurology [31]. However,
the development of guidelines has to be accompanied
by a broad discourse within a given profession that
includes their clients. It’s time that a broad discourse
starts within the disability community because if one
disability group accepts a push for enhancements this
will impact other groups within the disability com-
munity. Furthermore a broad societal discourse on
enhancements and the goals that drive their use is
needed. The report from the ethics committee of the
American Academy of Neurology seems not to have
triggered a broad response so far, although some
comment were generated [80].
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